Biogen (BIIB) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Biogen (BIIB) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (05:55)

Sector: Healthcare

The share price of Biogen Inc. (BIIB) now

What analysts predict: $332.78
52-week High/Low: $319.74 / $188.53

50/200 Day Moving Average: $294.99 / $272.54

This figure corresponds to the Average Price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the support level today.

For Biogen stocks, the 200-day moving average is the support level today.

Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2023, 2024, 2025, 2026, 2027. How much will one Biogen share be worth in 2023 - 2027?

When should I take profit in Biogen stock? When should I record a loss on Biogen stock? What are analysts' forecasts for Biogen stock? What is the future of Biogen stock? We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.




Historical and forecast chart of Biogen stock

The chart below shows the historical price of Biogen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.

Long-term forecasts by years.

Biogen daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 10 318.49 311.62 323.37 3.77
Jun 11 318.49 311.81 325.09 4.26
Jun 12 309.70 303.01 312.86 3.25
Jun 13 310.73 307.93 313.06 1.66
Jun 14 312.50 309.87 320.00 3.27
Jun 15 313.43 308.26 316.07 2.53
Jun 16 309.96 305.03 315.44 3.41
Jun 17 307.45 300.53 311.69 3.71
Jun 18 298.59 295.90 303.79 2.66
Jun 19 290.89 287.13 292.81 1.98
Jun 20 293.85 291.83 297.03 1.78
Jun 21 293.68 291.12 295.62 1.54
Jun 22 290.24 288.41 295.03 2.29
Jun 23 290.76 289.02 293.73 1.63
Jun 24 294.95 290.35 297.25 2.38
Jun 25 296.72 293.78 298.77 1.70
Jun 26 292.98 288.06 295.97 2.75
Jun 27 300.98 297.28 305.86 2.89
Jun 28 298.00 295.77 305.06 3.14
Jun 29 294.78 289.30 298.76 3.27
Jun 30 297.97 292.87 304.58 4.00
Jul 01 296.45 290.93 299.03 2.78
Jul 02 297.07 290.21 299.65 3.26
Jul 03 298.32 292.77 303.87 3.79
Jul 04 301.45 298.65 304.89 2.09
Jul 05 303.08 299.80 309.35 3.18
Jul 06 301.99 298.45 309.23 3.61
Jul 07 304.43 301.24 308.18 2.30
Jul 08 308.63 304.56 312.34 2.55
Jul 09 306.23 303.47 313.12 3.18

Biogen Daily Price Targets


Biogen Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $318.49.
Positive dynamics for Biogen shares will prevail with possible volatility of 3.634%.
Pessimistic target level: 311.62
Optimistic target level: 323.37

Biogen Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $318.49.
Negative dynamics for Biogen shares will prevail with possible volatility of 4.085%.
Pessimistic target level: 311.81
Optimistic target level: 325.09

Biogen Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $309.70.
Negative dynamics for Biogen shares will prevail with possible volatility of 3.148%.
Pessimistic target level: 303.01
Optimistic target level: 312.86

Biogen Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $310.73.
Positive dynamics for Biogen shares will prevail with possible volatility of 1.638%.
Pessimistic target level: 307.93
Optimistic target level: 313.06

Biogen Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $312.50.
Positive dynamics for Biogen shares will prevail with possible volatility of 3.164%.
Pessimistic target level: 309.87
Optimistic target level: 320.00

Biogen Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $313.43.
Positive dynamics for Biogen shares will prevail with possible volatility of 2.469%.
Pessimistic target level: 308.26
Optimistic target level: 316.07

BIIB (BIIB) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 328.44 310.50 346.71 10.44
Aug. 338.09 329.22 366.49 10.17
Sep. 346.97 321.46 372.83 13.78
Oct. 320.74 303.22 341.95 11.33
Nov. 315.35 299.12 322.63 7.29
Dec. 337.20 315.60 364.11 13.32

Biogen forecast for this year


Biogen Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $328.435. Pessimistic: $310.50. Optimistic: $346.71


Biogen Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $338.091. Pessimistic: $329.22. Optimistic: $366.49


Biogen Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $346.966. Pessimistic: $321.46. Optimistic: $372.83


Biogen Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $320.735. Pessimistic: $303.22. Optimistic: $341.95


Biogen Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $315.347. Pessimistic: $299.12. Optimistic: $322.63


Biogen Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $337.2. Pessimistic: $315.60. Optimistic: $364.11



Biogen (BIIB) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 372.61 363.22 403.51 9.99
Feb 374.95 358.42 387.16 7.42
Mar 392.28 376.63 417.81 9.86
Apr 426.88 409.84 449.74 8.87
May 396.40 384.74 417.21 7.78
Jun 366.43 352.58 395.67 10.89
Jul 361.81 342.06 379.29 9.82
Aug 352.31 329.38 378.21 12.91
Sep 363.41 351.20 372.19 5.64
Oct 350.82 340.51 367.40 7.32
Nov 348.98 320.40 373.16 14.14
Dec 333.96 325.19 341.32 4.73

Biogen (BIIB) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 337.81 320.43 360.51 11.12
Feb 332.85 309.08 355.21 12.99
Mar 314.32 300.46 336.77 10.78
Apr 303.10 280.51 319.33 12.16
May 311.70 304.50 331.66 8.19
Jun 340.82 313.98 359.43 12.64
Jul 369.45 350.06 396.61 11.74
Aug 400.10 386.23 418.58 7.73
Sep 386.66 357.42 417.92 14.47
Oct 389.50 378.05 411.99 8.24
Nov 382.95 355.21 410.70 13.51
Dec 386.57 358.97 399.16 10.07

Biogen (BIIB) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 365.47 347.81 384.65 9.58
Feb 401.92 381.66 433.15 11.89
Mar 401.08 379.60 419.19 9.44
Apr 382.97 369.30 401.87 8.10
May 417.95 391.18 438.14 10.72
Jun 424.53 400.91 436.12 8.07
Jul 450.83 434.74 478.29 9.11
Aug 486.81 467.39 515.44 9.32
Sep 503.68 479.88 537.53 10.72
Oct 520.07 486.22 559.94 13.17
Nov 542.46 504.30 583.47 13.57
Dec 517.97 503.83 558.22 9.74

Biogen (BIIB) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 514.71 503.90 539.03 6.52
Feb 540.11 510.05 573.00 10.99
Mar 554.29 533.33 569.42 6.34
Apr 547.30 503.05 572.59 12.14
May 600.75 579.30 622.82 6.99
Jun 627.87 598.20 677.97 11.77
Jul 639.08 609.55 662.56 8.00
Aug 645.79 594.93 679.69 12.47
Sep 658.67 617.87 702.93 12.10
Oct 692.56 653.29 737.65 11.44
Nov 717.28 685.65 760.97 9.90
Dec 645.74 609.12 674.21 9.65

Biogen information and performance

Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.

The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.

Official site of the company

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization: 43 730 903 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 3 377 600 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 13.88

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 36.19

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 21.76

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.296
Quarterly Revenue Growth YOY: -0.027
Trailing PE: 13.88

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 18.45

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.183

Enterprise Value (EV) /Revenue

EV To EBITDA: 10.36

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 144742000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.